Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, personal care and skincare products sold directly to Brand Partners and Preferred Customers across 25 global markets. Company news regularly centers on earnings releases, management commentary, omnichannel strategy, product innovation and channel expansion.
Recurring updates also cover product launches and quality validation for brands such as CellSentials, Celavive and Glow, along with the company’s controlling stake in Hiya Health Products, its ownership of Rise Wellness, athlete sponsorships and USANA Foundation activity.
USANA Health Sciences (NYSE: USNA) reported fiscal Q3 2021 results with net sales of $274.4 million, down 8% from the previous year. Diluted EPS was $1.36, a 6% decrease. Active customers dropped to 576,000, down 11%. The Asia Pacific region, contributing 81% of sales, saw net sales of $220.9 million (-9%). The company maintains its fiscal 2021 outlook for consolidated net sales of $1.18 - $1.20 billion and EPS of $5.80 - $6.00. USANA ended the quarter with $249 million in cash.
USANA announced that its Coenzyme Q10 supplement, CoQuinone 30, has received a purity and label accuracy seal from ConsumerLab.com. This marks the third time CoQuinone 30 has achieved this recognition. The product contains 100% of the claimed CoQ10 amount and combines CoQ10 with alpha-lipoic acid, enhancing its effectiveness for cellular energy and supporting cardiovascular health. USANA also has other certified products, including BiOmega and Procosa.
USANA Health Sciences (NYSE: USNA) appointed Xia Ding to its board of directors, effective October 11, 2021. Ms. Ding is currently Nike's Vice President of e-commerce for Asia Pacific and Latin America and brings extensive experience from leading companies like JD.com and Hanesbrands. With her expertise in digital business, USANA aims to enhance its strategic direction. Following this addition, the board comprises eight members, six of whom are independent. CEO Kevin Guest expressed optimism regarding Ms. Ding's contributions to the company’s growth.
USANA Health Sciences (NYSE: USNA) will announce its third quarter 2021 results after the close of the market on October 26, 2021. Following the earnings release, a Management Commentary document will be available on the company’s website. A conference call to discuss the results with analysts will take place on October 27, 2021, at 11:00 AM ET. The call will be accessible via the Investor Relations section of their site.
For further information, visit ir.usana.com.
USANA congratulates board member Peggie Pelosi for being named one of the most influential leaders by the National Association of Corporate Directors (NACD). This recognition is part of the NACD Directorship 100™, which honors corporate governance experts and directors who significantly impact boardroom practices. Pelosi's contributions to sustainability and corporate social responsibility have been highlighted, and she will be recognized at a virtual gala on November 9, 2021. Her leadership is praised by Kevin Guest, USANA's CEO.
USANA Health Sciences has collaborated with Dr. Mehmet Oz and Dr. Anlong Xu to publish Yin Yang You, a book that integrates Traditional Chinese Medicine (TCM) with Western health practices. Launched at the 2021 Concordia Annual Summit, this innovative guide aims to demystify TCM for Western audiences, offering practical insights and recipes. The collaboration emphasizes enhancing understanding of holistic health and aims to bridge the gap between Eastern and Western medicine, promoting global awareness and effectiveness in health practices.
USANA Health Sciences (NYSE: USNA) has announced preliminary results for Q3 2021, reporting net sales between $265 and $270 million, down from $299 million year-over-year. Earnings per share (EPS) are projected between $1.28 and $1.33, compared to $1.44 in Q3 2020. The company cites increased disruptions due to COVID-19 as a key factor impacting sales. Despite these challenges, USANA maintains a full-year sales growth outlook of 4% to 6% compared to last year.
USANA, a provider of cellular nutrition products, has received its third seal of approval from ConsumerLab.com for its Procosa joint-support supplement. This recognition confirms that Procosa contains 100% of the claimed amounts of glucosamine and turmeric, essential for joint health. The supplement also meets strict standards for heavy metals and disintegration levels. Dan Macuga, USANA's CMO, highlighted the company's dedication to quality in its products. USANA's reputation for high-quality supplements is further strengthened by multiple certifications from ConsumerLab.com, reinforcing its commitment to consumer trust.
USANA, a leading nutritional supplement company, celebrated its para athletes during the Tokyo Paralympics, where they achieved 13 podium finishes: 7 gold, 3 silver, and 3 bronze medals. Noteworthy performances include Nick Mayhugh, who set multiple world records and won four medals, and Jessica Long, who solidified her legacy with six medals. This commendable success underscores USANA's commitment to high-quality products, trusted by top athletes worldwide. To learn more about USANA, visit USANA.com.
USANA Health Sciences CEO Kevin Guest highlights the importance of resilience in the workplace, particularly as September is declared National Self-Improvement Month. Guest outlines ten strategies for individuals to enhance their resilience, such as strengthening self-relationships, exercising, and socializing with resilient people. He emphasizes that resilient employees are more motivated and adaptable. Furthermore, 100% of the sales from Guest's book will support the USANA Foundation, which aids impoverished families.